In the present study, it was found that from CK19+/GPC3+ HCC to CK19−/GPC3+ HCC, and then CK19−/GPC3− HCC, tumor cell in intrahepatic metastasis, microvascular invasion, regional lymph node involvement, and distant metastasis was decreased. Here, GPC3 is linked to hepatocellular carcinoma.